BIOMAT Database Logo BIOMAT Database Logo

Pharmacological characterization of PF-00547659, an anti-human MAdCAM monoclonal antibody. 2009

N Pullen, and E Molloy, and D Carter, and P Syntin, and F Clemo, and D Finco-Kent, and W Reagan, and S Zhao, and T Kawabata, and S Sreckovic
Pfizer Global Research and Development, Sandwich, Kent, UK. nick.pullen@pfizer.com

OBJECTIVE The adhesion molecule mucosal addressin cell adhesion molecule (MAdCAM) plays an essential role in the recruitment of lymphocytes to specialized high endothelial venules of the gastrointestinal tract and in their excessive tissue extravasation observed in inflammatory conditions, such as Crohn's disease. We have characterized the in vitro pharmacological properties of two monoclonal antibodies blocking MAdCAM, MECA-367 and PF-00547659, and determined their pharmacokinetic/pharmacodynamic profiles in vivo. METHODS Functional adhesion assays and surface plasmon resonance were used to characterize, in vitro, the pharmacological properties of MECA-367 and PF-00547659. The in vivo effects of MECA-367 and PF-00547659 on restriction of beta(7) (+) memory T lymphocytes were determined in mice and macaques, respectively, over the pharmacological dose range to confirm pharmacokinetic/pharmacodynamic relationships. RESULTS MECA-367 and PF-00547659 bound with high affinity to mouse and human MAdCAM with K(d) values of 5.1 and 16.1 pmol.L(-1) respectively and blocked the adhesion of alpha(4)beta(7) (+) leukocytes to MAdCAM with similar potency. MECA-367 and PF-00547659 induced a similar, dose-dependent two- to threefold increase in circulating populations of beta(7) (+) memory T-cells in the mouse and macaque; without affecting the beta(7) (-) populations. CONCLUSIONS PF-00547659 has potential utility in the treatment of inflammatory conditions by blocking tissue homing of activated alpha(4)beta(7) (+) leukocytes. The characterization of a rodent cross-reacting antibody as a surrogate for PF-00547659 in the search for potential pharmacological biomarkers and the determination of efficacious doses was effective in addressing the restricted orthologous cross-reactivity of PF-00547659 and the challenges this poses with respect to efficacy and safety testing.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

N Pullen, and E Molloy, and D Carter, and P Syntin, and F Clemo, and D Finco-Kent, and W Reagan, and S Zhao, and T Kawabata, and S Sreckovic
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.
July 2017, Lancet (London, England),
N Pullen, and E Molloy, and D Carter, and P Syntin, and F Clemo, and D Finco-Kent, and W Reagan, and S Zhao, and T Kawabata, and S Sreckovic
Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn's disease in Japanese and Korean patients: the OPERA study.
January 2020, Intestinal research,
N Pullen, and E Molloy, and D Carter, and P Syntin, and F Clemo, and D Finco-Kent, and W Reagan, and S Zhao, and T Kawabata, and S Sreckovic
Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study.
October 2018, Gut,
N Pullen, and E Molloy, and D Carter, and P Syntin, and F Clemo, and D Finco-Kent, and W Reagan, and S Zhao, and T Kawabata, and S Sreckovic
Clinical pharmacokinetic assessment of an anti-MAdCAM monoclonal antibody therapeutic by LC-MS/MS.
July 2012, Analytical chemistry,
N Pullen, and E Molloy, and D Carter, and P Syntin, and F Clemo, and D Finco-Kent, and W Reagan, and S Zhao, and T Kawabata, and S Sreckovic
Characterization of an anti-thioredoxin monoclonal antibody.
February 2006, Biotechnology letters,
N Pullen, and E Molloy, and D Carter, and P Syntin, and F Clemo, and D Finco-Kent, and W Reagan, and S Zhao, and T Kawabata, and S Sreckovic
Characterization of human rhinoviruses displaced by an anti-receptor monoclonal antibody.
July 1988, Journal of virology,
N Pullen, and E Molloy, and D Carter, and P Syntin, and F Clemo, and D Finco-Kent, and W Reagan, and S Zhao, and T Kawabata, and S Sreckovic
Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use.
January 2014, mAbs,
N Pullen, and E Molloy, and D Carter, and P Syntin, and F Clemo, and D Finco-Kent, and W Reagan, and S Zhao, and T Kawabata, and S Sreckovic
Characterization of human anti-hrB-like monoclonal antibody.
January 1996, Immunohematology,
N Pullen, and E Molloy, and D Carter, and P Syntin, and F Clemo, and D Finco-Kent, and W Reagan, and S Zhao, and T Kawabata, and S Sreckovic
Structural and functional characterization of an agonistic anti-human EphA2 monoclonal antibody.
October 2011, Journal of molecular biology,
N Pullen, and E Molloy, and D Carter, and P Syntin, and F Clemo, and D Finco-Kent, and W Reagan, and S Zhao, and T Kawabata, and S Sreckovic
Humanization and characterization of an anti-human TNF-α murine monoclonal antibody.
January 2011, PloS one,
Copied contents to your clipboard!